drugset / Trial / NCT00272935
A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind study to compare the efficacy and safety of daily doses of Cenestin 0.3 mg tablets to placebo in reducing the frequency and severity of moderate to severe hot flashes in postmenopausal women.
Timeline
- Start
- 2005-12
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ESTROGENS, CONJUGATED SYNTHETIC A | Unknown | 0.3 mg | — |
Indications
No indication recorded.